Time for a gut check: Pancreatic sufficiency resulting from CFTR modulator use
- PMID: 31066218
- DOI: 10.1002/ppul.24353
Time for a gut check: Pancreatic sufficiency resulting from CFTR modulator use
Abstract
Pancreatic exocrine insufficiency in cystic fibrosis is genetically determined and generally felt to be irreversible. However, recent studies in young children started on cystic fibrosis transmembrane conductance regulator (CFTR) modulators have suggested improvement of pancreatic functioning over time. Here, we present the case of a 10-year-old child with pancreatic exocrine insufficiency since birth who regained pancreatic functioning after 4 years on the CFTR corrector drug, ivacaftor.
Keywords: cystic fibrosis; modulator therapy; pancreatic insufficiency.
© 2019 Wiley Periodicals, Inc.
Comment in
-
Pancreatic insufficiency converted to pancreatic sufficiency with ivacaftor.Pediatr Pulmonol. 2019 Nov;54(11):1654. doi: 10.1002/ppul.24454. Epub 2019 Jul 21. Pediatr Pulmonol. 2019. PMID: 31328424 No abstract available.
-
Sustained recovery of exocrine pancreatic function in a teenager with cystic fibrosis treated with ivacaftor.Pediatr Pulmonol. 2020 Oct;55(10):2493-2494. doi: 10.1002/ppul.24952. Epub 2020 Jul 17. Pediatr Pulmonol. 2020. PMID: 32678518 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical